|
 |
ReminylThis page contains recent news articles, when available, and an overview of Reminyl but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Reminyl (when available) Galantamine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor. Galantamine is indicated for the treatment of mild to moderate dementia of the Alzheimer's type. Galantamine is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. If this proposed mechanism of action is correct, Galantamine's effect may lessen as the disease process advances and fewer cholinergic neurons remain functionally intact. There is no evidence that Galantamine alters the course of the underlying dementing process. For the treatment of mild to moderate dementia of the Alzheimer's type. Mechanism Of Action: Galantamine's proposed mechanism of action involves the increase of the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. News Articles on Galantamine Woodstock man faces early diagnosis - Dec 30, 2009 Eventually, Chait was diagnosed in Canada in January 2008 and prescribed Reminyl, a drug designed to slow the progression of the disease. ... Oxford Review REG-Shire plc: 3rd Quarter Results - Oct 30, 2009 Report on Form 10-Q for the six months ended June 30, 2009. 1 REMINYL® and REMINYL XL™ are both trademarks of Shire in the UK and Republic of Ireland. END. Reuters Demographic time bomb - Nov 2, 2009 In its original decision, NICE decided not to recommend the reimbursement of Aricept, Novartis' Exelon (rivastigmine) and Shire's Reminyl (galantamine), ... Pharmaceutical Technology Magazine Shire hit by safety worries over Alzheimer's treatment - Jan 25, 2005 Three times as many patients using Reminyl died during the course of a two-year ... Reminyl will no longer be pursued as a possible senility treatment, ... Independent Reminyl Deaths Prompt Warning - Apr 5, 2005 By Daniel J. DeNoon. April 5, 2005 -- The deaths of 13 elderly patients taking the Alzheimer's drug Reminyl during a study has prompted a change to the ... WebMD Safety Concerns Reported on J.& J. Alzheimer's Drug - Jan 22, 2005 Reminyl is approved in 69 countries as a treatment for mild to moderate ... In the trials, which lasted two years, 15 patients taking Reminyl died compared ... New York Times Shire welcomes Nice decision that Alzheimer's drugs to remain... - Jan 23, 2006 John Freeman, managing director of Shire Pharmaceuticals' UK operation, which markets Reminyl(R) and Reminyl XL in the UK, said: 'This is good news for new ... Forbes Alzheimer's drugs fight goes to court - Jun 25, 2007 The drugs Aricept, Exelon and Reminyl can delay the decline of memory and ability to function by six months in many patients at both the mild and moderate ... Telegraph.co.uk Alzheimer's drug ban to stay, court rules - Aug 11, 2007 ...by the drug's rationing body, the National Institute for Health and Clinical Excellence (Nice), to ban three new drugs, Aricept, Reminyl and Exelon. ... Telegraph.co.uk NHS drug decision under attack - Mar 2, 2005 It said that the three drugs available for treatment of mild to moderate dementia - Aricept (donepezil), Exelon (rivastigmine) and Reminyl (galantamine), ... guardian.co.uk UK Alzheimer's drug case ends, judgement reserved - Jun 29, 2007 Other products affected by NICE's decision are Exelon from Novartis AG, Ebixa from Lundbeck A/S and Reminyl from Shire Plc, which is sold elsewhere by ... Reuters India No drugs please, we're really ill - Aug 20, 2007 The National Institute for Health and Clinical Excellence (Nice) ruled last year that Aricept, Exelon and Reminyl were cost-effective only in patients with ... Times Online Alzheimer's drug cuts challenged - Mar 13, 2005 Aricept, Exelon, Reminyl and Ebixa are the only drugs licensed in Britain for the treatment of the disease. The National Institute for Clinical Excellence, ... BBC News Pfizer, Eisai can appeal UK Alzheimer drug verdict - Dec 5, 2007 CO) and Reminyl from Shire Plc (SHP.L), which is sold elsewhere by Johnson & Johnson (JNJ.N) as Razadyne. (Reporting by Ben Hirschler; Editing by David ... Reuters … Investigational Study Involving REMINYL(R) (Galantamine Hydrobromid - Jan 21, 2005 REMINYL is an acetylcholinesterase inhibitor currently approved in 69 countries ... Mortality rates were low in both the REMINYL and placebo groups in this ... RedOrbit Reminyl May Benefit Those Suffering From Severe Alzheimer's Disease (... - Dec 1, 2008 ...(December 1, 2008 - Insidermedicine) A drug used to slow progression of mild-to-moderate Alzheimer's may be beneficial even for those whose condition has ... Insidermedicine Label of drug for Alzheimer's adds warning - Apr 3, 2005 Johnson & Johnson has added a new warning to the label of Reminyl, ... The two studies, involving more than 2000 patients, were testing Reminyl as a ... $2.95 - Philadelphia Inquirer - NewsBank Clinical news - In brief: Reminyl discontinued.(Brief article) - May 27, 2006 Reminyl 4mg tablets (galantamine hydrochloride) are being discontinued due to a lack of demand. Manufacturer Shire says the product will be available until ... Free with registration - Chemist & Druggist - AccessMyLibrary.com does reminyl cause sleepiness - May 8, 2008 Nausea, vomiting, diarrhea, dizziness, loss of appetite, and weight loss may occur. If any of these effects persist or worsen, notify your doctor or ... HealthCentral.com … : whose quality of life?(observations)(Aricept, Exelon and Reminyl) - Mar 14, 2005 ...(Nice) has decided that no new Alzheimer's patients should start on any of the available drugs, Aricept, Exelon or Reminyl, may look clear cut. ... Pay-Per-View - New Statesman - Factiva, from Dow Jones Dementia - Treatment Overview - Jun 27, 2007 Cholinesterase inhibitors such as donepezil (Aricept), galantamine (Reminyl), or rivastigmine (Exelon), to improve or maintain mental function. ... WebMD British NICE backs limited use of Alzheimer's drugs.(Briefly Noted)(Br... - Jan 30, 2006 The three market leaders in anti-cholinesterase drugs are Pfizer and Eisai Co.'s Aricept, Johnson & Johnson and Shire's Reminyl, and Novartis AG's Exelon. Free with registration - Mental Health Weekly - AccessMyLibrary.com Reminyl renamed Razadyne.(News Notes)(Brief Article) - May 1, 2005 In order to support patient safety in prescribing and dispensing Reminyl (galantamine), a drug that is indicated in Alzheimer's disease, Ortho-McNeil ... Free with registration - Brown University Geriatric Psychopharmac... - AccessMyLibrary.com Outcry as dementia drug rules published - Nov 22, 2006 Patients with newly-diagnosed dementia are unlikely to be prescribed three drugs - Aricept, Reminyl or Exelon - which have been previously available on the ... Northern Echo - The Northern Echo Is NICE facing more days in court?(National Institute for Clinical … - Dec 1, 2006 Shire pharmaceuticals, which makes Reminyl, has already offered its support to the other pharmaceutical companies pursuing the case. ... Free with registration - GP - AccessMyLibrary.com Article: Johnson & Johnson Reports Reminyl Deaths - AP Online | … - Jan 21, 2005 Johnson & Johnson Reports Reminyl Deaths ... find AP Online articles. AP Online 01-21-2005 Dateline: RARITAN, NJ Patients taking Alzheimer's drug Reminyl in ... Pay-Per-View - AP Online - HighBeam Research Clinical news - In brief: Reminyl discontinued. - May 27, 2006 Clinical news - In brief: Reminyl discontinued. Reminyl 4mg tablets (galantamine hydrochloride) are being discontinued due to a lack of demand. ... $9.94 - Chemist & Druggist - Alacra Store Canadian Study Shows Treatment For Alzheimer's Disease Can … - Apr 16, 2007 Fifty-eight per cent of patients on REMINYL® experienced a reduction in ... Patients were randomly assigned to either treatment with REMINYL® (16-24 mg) or ... Medical News Today - Medical News Today (press release) Treatment that buys an extra year of clarity - Mar 2, 2005 Reminyl (galantamine) was launched in 2000 and has the advantage of acting on different receptors in the brain. The drug, made by Hampshire based Shire ... Daily Mail Health campaigners welcome drugs probe - Feb 3, 2007 His 83-year-old wife Pamela has taken Reminyl for the past three years and his brother Richard, 77, has just been diagnosed with early stage dementia. ... Norwich Evening News Alzheimer Disease; Reminyl XL now available in UK and Ireland - Jul 12, 2005 2005 JUL 12 - (NewsRx.com) -- Shire Pharmaceuticals Group plc (SHP, SHPGY, SHQ) announces that Reminyl XL (galantamine hydrobromide) prolonged release ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Healthcare: GCI's healthcare staff to move in with C&W team.(Brief... - Jan 27, 2006 GCI UK clients are believed to include Shire Pharmaceuticals (on Alzheimer's drug Reminyl, see At A Glance opposite), Merck Sharp & Dohme, Medtronic and ... Free with registration - PR Week - AccessMyLibrary.com J&J's new data on Reminyl in mild cognative impairment shows higher … - Jan 31, 2005 Johnson & Johnson Pharmaceutical Research & Development says that health authorities are reviewing scientific data from two clinical trials evaluating an ... $4.95 - Pharma Marketletter - ECNext Article: Reminyl renamed Razadyne to end Rx mix-ups.(Psychiatry) - … - May 15, 2005 Reminyl renamed Razadyne to end Rx mix-ups.(Psychiatry) ... find Internal Medicine News articles. Reminyl, indicated for mild to moderate Alzheimer's ... Pay-Per-View - Internal Medicine News - HighBeam Research Alzheimer's disease.(disease overview)(Disease/Disorder overview) - May 24, 2006 Some doctors believe medicines such as donepezil (Aricept), galantamine (Reminyl), and rivastigmine (Exelon) can be used early in Alzheimer's disease to ... $4.95 - Clinical Reference Systems - ECNext Article: Reminyl renamed Razadyne to end mix-ups with diabetes rx.( … - May 1, 2005 Reminyl renamed Razadyne to end mix-ups with diabetes rx.(News)(Brief Article) ... find Clinical Psychiatry News articles. Reminyl, indicated for mild to ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research NICE (National Institute for Health and Clinical Excellence) Issues... - Oct 21, 2005 With Reminyl and Reminyl XL having been proven as clinically effective for ... Shire markets the acetylcholinesterase inhibitor Reminyl(R) and Reminyl XL ... prnewswire.co.uk … Disease; Health authorities review data from Reminyl clinical... - Feb 14, 2005 Reminyl is an acetylcholinesterase inhibitor currently approved in 69 countries ... Mortality rates were low in both the Reminyl and placebo groups in this ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones Monday Morning Market: Shire slumps on Reminyl fears - Jan 24, 2005 By Dylan Lobo | 09:54:14 | 24 January 2005. Get up to the minute share prices for UK stocks at Citywire's FTSE Share Prices & Performance zone. ... Citywire.co.uk FDA Cautions Against Use of Reminyl for Mild Cognitive Impairment - Apr 1, 2005 Editor's note: Ortho-McNeil Neurologics, Inc., announced on April 11, 2005, that its brand name Reminyl (galantamine hydrobromide) would be changed to ... Medscape … Disease; Health authorities review data from Reminyl clinical... - Feb 19, 2005 Reminyl is an acetylcholinesterase inhibitor currently approved in 69 countries ... Mortality rates were low in both the Reminyl and placebo groups in this ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones … Disease; Health authorities review data from Reminyl clinical... - Feb 15, 2005 Reminyl is an acetylcholinesterase inhibitor currently approved in 69 countries ... Mortality rates were low in both the Reminyl and placebo groups in this ... Pay-Per-View - Science Letter - Factiva, from Dow Jones … Reviewing Safety Data from Investigational Study Involving REMINYL(... - Jan 21, 2005 REMINYL is an acetylcholinesterase inhibitor currently approved in 69 countries ... Mortality rates were low in both the REMINYL and placebo groups in this ... Pay-Per-View - PR Newswire - HighBeam Research Reminyl labeling updated to reflect mortality data.(BREAKING NEWS... - Apr 18, 2005 Ortho-McNeil Neurologics has modified the prescribing information for galantamine (Reminyl), which is approved for the treatment of mild to moderate ... Free with registration - Drug Topics - AccessMyLibrary.com Trial Deaths Prompt Ortho-McNeil to Modify Precautions on Reminyl - Apr 12, 2005 Ortho-McNeil Neurologics has updated prescribing information on its Alzheimer's drug Reminyl to disclose recent deaths among patients participating in two ... Pay-Per-View - FDAnews Drug Daily Bulletin - Factiva, from Dow Jones Deterioramento cognitivo lieve: Reminyl non rallenta la conversione a... - Aug 11, 2008 Lunedì 11 Agosto 2008 - Ricercatori del Karolinska Intitutet a Stoccolma in Svezia hanno valutato la sicurezza della Galantamina ( Reminyl ) nei soggetti ... XagenaSalute Death link query over Reminyl.(Brief Article) - Feb 5, 2005 A study has linked Reminyl (galantamine hydrobromide) to slightly higher mortality rates when used in patients with mild cognitive impairment, ... Free with registration - Chemist & Druggist - AccessMyLibrary.com Article: Rx mix-ups prompt Reminyl name change.(Geriatric Psychiatry)(... - Jan 1, 2005 Rx mix-ups prompt Reminyl name change.(Geriatric Psychiatry)(Brief Article) ... find Clinical Psychiatry News articles. Janssen Pharmaceutica has agreed to ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research NICE calls for more Alzheimer's evidence to head off row - Jul 20, 2005 In March this year, NICE shocked patient groups and the companies when it said the three treatments - Aricept, Exelon and Reminyl - were not cost-effective ... Pharmafocus Galantamine (Reminyl®) geregistreerd voor symptomatische … - Dec 20, 2008 Galantamine is in Nederland geregistreerd voor de symptomatische behandeling van milde tot matig ernstige vorm van de ziekte van Alzheimer. ... Medical facts Article: Reminyl safety watch.(investigations)(Brief Article) - Feb 7, 2005 The acetylcholinesterase inhibitor Reminyl (galantamine hydrobromide) is being reinvestigated by safety watchdogs, after two clinical trials suggested it ... Pay-Per-View - Chemistry and Industry - HighBeam Research Study of Alzheimer's Drug Revives Questions on Risk - Mar 17, 2006 Far more of the patients given Reminyl died than did those who received placebos, Dr. Schneider said. No other large trials have found a similar risk, ... New York Times Lyckad bromsmedicin mot Alzheimer - Oct 17, 2007 Nästan hälften av 143 Alzheimersjuka patienter som behandlats med bromsmedicinen Reminyl har under en treårsperiod behållit eller i vissa fall förbättrat ... Sveriges Television Läkemedel mot alzheimer har effekt - Jan 25, 2006 Alzheimermediciner som Aricept, Reminyl och Exelon fungerar och bromsar symtomen ... Hon fick alzheimerläkemedlet Reminyl ganska direkt efter diagnosen. ... Dagens Nyheter Pérdida de memoria no se corrige con drogas para el Alzheimer - Nov 29, 2007 Tres fármacos de primera línea (Aricept donepezil; Exelon o rivastigmina y Reminyl o galantamina) están autorizados para tratar el mal de Alzheimer de leve ... La Nación Costa Rica Concerns grow over Alzheimer drugs - Jan 31, 2005 He's concerned the threefold higher rate of death in the Reminyl trial, ... The drugs are known to affect the heart and many deaths in the Reminyl trial ... CBC.ca Calidad de vida - eluniversal.com - Aug 8, 2006 Los investigadores dieron a los animales altas dosis de veneno y los trataron con Reminyl, conocido genéricamente como galantamina, junto con atropina, ... El Universal - El Universal (Venezuela) Atlanta health, diet and fitness news | ajc.com - Jan 22, 2005 During the two year trial period, 15 patients taking Reminyl died, as opposed to five who were taking a placebo, according to the Times. ... Atlanta Journal Constitution Testing squashes new use for drug | Article from The Record (Bergen … - Jan 23, 2005 RARITAN - Patients taking the Alzheimer's drug Reminyl in a test for another use had ... Reminyl was approved in 2001 as a treatment for mild to moderate ... Pay-Per-View - The Record - HighBeam Research 'Reclame Alzheimer misleidend' - Dec 4, 2008 Het bedrijf brengt sinds 2003 het middel Reminyl (galantamine) op de markt. ... Het effect van Reminyl, een cholinesteraseremmer, is zeer beperkt. ... Trouw Autorizada en España la dosis única diaria de Reminyl (galantamina) - Jan 18, 2007 La Agencia Española del Medicamento ha aprobado la dosis única diaria de galantamina, una nueva versión del tratamiento contra la enfermedad de Alzheimer ... doyma.es Shire plc: IFRS Information - First Half of 2006. - Sep 18, 2006 ...excluding UK and REMINYL XL Republic of Ireland) (trademark of Johnson ... n/a FOSRENOL 13.9 14.8 -6 +62 CALCICHEW 22.1 18.2 +21 n/a REMINYL/REMINYL XL ... $4.95 - PR Newswire - ECNext Safety Concerns Halt Alzheimer's Drug Trials - Jan 25, 2005 After consulting with Food and Drug Administration regulators, Johnson & Johnson said the safety of its drug Reminyl is now under review. ... Consumer Affairs Alzheimer's sufferers win landmark court appeal over denied drugs - May 1, 2008 At present, Aricept, Exelon and Reminyl are restricted to those with ... It was estimated that withholding Aricept, Exelon and Reminyl from those who could ... Daily Mail Press Release: SHIRE PLC - IFRS results for the year ending December ... - Mar 23, 2007 OTHER Other royalties are primarily in respect of REMINYL and REMINYL ER (known ... Sales of the REMINYL/ RAZADYNE range, for the symptomatic treatment of ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research Reminyl® (galantamine) et mortalité : Résultats de deux essais... - Jan 24, 2005 Reminyl® (galantamine) est un médicament indiqué uniquement dans le traitement des symptômes de la maladie d'Alzheimer, dans ses formes légères à modérées. ... InformationHospitaliere.com Twijfel over veiligheid dementiepil (Gerectificeerd) - Mar 12, 2005 Het gaat om galantamine (merknaam: Reminyl), dat sinds 2003 in Nederland op de markt is. Reminyl wordt nog vrijwel niet voorgeschreven in Nederland, ... Trouw Demenza: limitazioni del NICE sull'impiego dei farmaci anticolinestera... - Dec 13, 2006 Il Donepezil ( Aricept ), la Galantamina ( Reminyl ) e la Rivastigmina ( Exelon ) non dovrebbero essere prescritti nelle persone con forma moderata della ... XagenaSalute Twijfel over veiligheid dementiepil - Aug 15, 2005 Het gaat om galantamine (merknaam: Reminyl), dat sinds 2003 in Nederland op de markt is. Reminyl wordt nog vrijwel niet voorgeschreven in Nederland, ... Trouw Galantamin (Reminyl) führt möglicherweise zu einer höheren … - May 20, 2005 Die US-amerikanische Federal Drug Administration (FDA) - das staatliche Kontrollorgan für pharmazeutische Produkte - überprüft derzeit die Sicherheit von ... innovations report IFRS Information - First Half of 2007. - Sep 13, 2007 1.1.1.1.6GP CALCICHEW 25.6 22.1 +16 N/A CARBATROL 33.4 30.3 +10 -5 REMINYL/REMINYL XL 14.6 9.3 +57 N/A XAGRID 31.6 26.2 +21 N/A Other product sales 52.6 ... $4.95 - PR Newswire - ECNext Shire hit hard by trial drug deaths.(Business) | Article from The … - Jan 25, 2005 He estimated Reminyl represents around three per cent of Shire's 2004 revenues ... 'Even assuming Reminyl remains on the market after the conclusion of the ... Pay-Per-View - Birmingham Post - HighBeam Research How can they deny people this drug? - Oct 11, 2006 But Mrs Phelps, who takes Reminyl, said it was vital all patients received it as ... She said: "Everyone I have contact with who takes Reminyl says it has ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com Clinical Alerts: SPC Changes. - May 24, 2008 Reminyl Oral Solution, Reminyl Tablets , Reminyl XL 8mg, 16mg and 24mg prolonged release capsules Extensive revisions following periodic safety assessment. ... $9.94 - Chemist & Druggist - Alacra Store How Alzheimer's slowly steals your life away... - Feb 27, 2007 Drugs with the brand names Aricept, Exelon and Reminyl are all known as ... In 2001, NICE ruled Aricept, Exelon and Reminyl should be used as standard. ... Daily Mail Alzheimer-Medikament als Gegengift chemischer Waffen! - Aug 8, 2006 Galantamine, das unter dem Markennamen Reminyl und Razadyne bei der Alzheimer ... Allerdings haben diese beiden Substanzen einen Nachteil, den Reminyl nicht ... BörseGo.de NICE must throw open the files on Alzheimer drug ruling - Oct 30, 2008 The three anti-cholinesterase drugs Aricept, Exelon and Reminyl can only be prescribed for those with moderate symptoms of Alzheimer's, not those in the ... Daily Mail Service with a smile is just the business to save London - Jan 25, 2005 Now it is the turn of Shire Pharmaceuticals to feel the chill on reports of death among patients taking its Alzheimer's product Reminyl. ... Scotsman Protest at withdrawal of Alzheimer drugs - Jan 3, 2006 NICE have proposed that the Anticholinestarase drugs, Aricept, Exelon and Reminyl should only be prescribed for Alzheimer sufferers who have deteriorated to ... News Wales Shire appeals against NICE Alzheimer's decision - Jun 15, 2006 The decision will mean that many patients will not receive the acetylcholinesterase inhibitors Reminyl and Reminyl XL, despite their success in clinical ... Hays Pharma BRIEFLY - Jan 22, 2005 Reminyl, which was approved in 2001 and had estimated 2003 sales of over $200 million, is approved for patients with mild to moderate dementia caused by ... Pay-Per-View - Star-Ledger - Factiva, from Dow Jones Article: J&J sues to block Sandoz generic Alzheimer's drug - The... - May 4, 2007 ...(trademark of Johnson & Johnson) RAZADYNE ER (trademark of Johnson & Johnson) (trademark of Johnson & Johnson, excluding UK and REMINYL XL Republic ... ... Pay-Per-View - The Record - HighBeam Research NJ BRIEFS | Article from The Record (Bergen County, NJ) | HighBeam … - Apr 12, 2005 NEW BRUNSWICK - Johnson & Johnson will change the name of the Reminyl drug, ... Reminyl will be renamed Razadyne on July 1, Ortho-McNeil Neurologics Inc., ... Pay-Per-View - The Record - HighBeam Research Press Release: Shire is Appealing Against the National Institute for... - Jun 15, 2006 Shire markets the acetylcholinesterase inhibitor Reminyl(R) and Reminyl XL ... NICE acknowledges that Reminyl and the other two acetylcholinesterase ... Pay-Per-View - PR Newswire Europe - HighBeam Research Chevron buying Unocal - Apr 11, 2005 In other news, Johnson & Johnson added new information to the label of its Alzheimer's treatment, Reminyl, about the deaths of patients who took the drug in ... $1.95 - Dow Theory Forecasts - Horizon Publishing Company Article: Shire on the sicklist after Alzheimer's trial setback. - The... - Jan 24, 2005 FEARS over the future of its Alzheimer's treatment Reminyl left Shire ... Brokers say Reminyl generates between $30 million ([pounds sterling]16 million) ... Pay-Per-View - Evening Standard - HighBeam Research … to change the name of its Alzheimer's therapy Reminyl to Razadyne... - Jun 1, 2005 FDA has ordered Ortho-McNeil Neurologics to change the name of its Alzheimer's therapy Reminyl to Razadyne to avoid prescribing errors with Sanofi-Aventis' ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Article: Postmarket reports spur new modafinil warnings.(Psychiatry) ... - Jan 1, 2008 Article: Reminyl renamed Razadyne to end Rx mix-ups.(Psychiatry) ... McNeil Neurologics agreed to add a precaution to its Reminyl labeling, and the company ... Pay-Per-View - Internal Medicine News - HighBeam Research Alzheimer drugs don't delay dementia onset -study - Nov 26, 2007 Reminyl is sold by Shire Plc (SHP.L) and also by Johnson & Johnson (JNJ.N) under the brand name Razadyne. A row over who should get these drugs ended up in ... Reuters Press Release: Intellect Neurosciences, Inc. to Present Data on … - Aug 20, 2007 We hope Reminyl(TM) will improve the lives ... caregivers affected by Alzheimer's disease." "We are ... of effects of Reminyl(TM) covering behavioural ... ... Pay-Per-View - PR Newswire - HighBeam Research How the treatments work - Aug 11, 2007 Aricept, Exelon and Reminyl stop an enzyme from breaking down ... Reminyl also appears to make nicotinic neuronal receptors in the body's tissues release ... Telegraph.co.uk Driving ban for Dench daughter - Mar 1, 2005 ...the National Institute for Clinical Excellence will say that the cost of rivastigmine (Exelon) donepizil (Aricept), galatamine (Reminyl) and memantine ... Times Online Health charities get 'covert' aid from drug firms - Dec 3, 2006 The Alzheimer's Society has led a patient campaign against a Nice ruling that the dementia drugs Aricept, Reminyl and Exelon were not cost-effective and ... Times Online Alzheimer's pill may be antidote to pesticides - Aug 9, 2006 They said the drug, marketed under the name Reminyl and Razadyne, ... Albuquerque said he has tested other drugs in the same class as Reminyl, ... GulfNews Nathan Hitzeman, MD, Sutter Health Family Medicine Residency Program … - Sep 1, 2006 Galantamine (Razadyne [previously Reminyl]) is started at a dosage of 4 mg twice daily and gradually titrated to 12 mg twice daily with step-ups at one- to ... AAFP News Now Alzheimer's drug linked to higher mortality.(News)(Brief Article) - Mar 1, 2005 The acetylcholinesterase inhibitor, manufactured under the name Reminyl by Johnson ... Reminyl is approved for the treatment of mild to moderate Alzheimer's ... Free with registration - Clinical Psychiatry News - AccessMyLibrary.com Patients in limbo over Alzheimer's drug - Jul 21, 2006 Mr Harvey, from Postwick, said: “My wife has been taking Reminyl for two years and during that time things have not deteriorated. ... Norwich Evening News Campaigners back court challenge on Alzheimer's drug - Feb 7, 2007 John Harvey's 83-year-old wife Pamela has taken Reminyl for the past three ... My wife's condition has levelled out because she has been on Reminyl but my ... Norwich Evening News Anticholinesterase Inhibitors - Sep 8, 2007 Reminyl (galantamine), Aricept (Donepezil) and Exelon (rivastigmine) are used in the ... In addition, Reminyl (galantamine) also increases the action of ... Virtual Medical Centre - The Virtual Medical Centre Alerta en EE.UU. por la muerte de 13 pacientes que tomaban Reminyl - Apr 2, 2005 MADRID. La compañía farmacéutica Johnson Johnson ha añadido una nueva etiqueta de advertencia en el fármaco «Reminyl» (galantamina) después de comprobar la ... ABC.es Alzheimer : efficacité contestée d'un médicament - Jan 28, 2005 Le Reminyl® a été autorisé en France en octobre 2002 suite à des essais ... Suite à ces nouveaux résultats, l'Afssaps rappelle que le Reminyl® n'est pas ... nouvelobs.com Sea su propio médico - Feb 26, 2005 El ejemplo de Reminyl ilustra la discusión que desde hace años mantienen las agencias reguladoras del medicamento acerca de la conveniencia de hacer más ... elmundo.es Alzheimer - wer kann helfen? - Jul 2, 2008 Nach 6 Monaten mussten wir wieder zur Nervenärztin wegen der teuren Medikamente (Reminyl), nur so bekommen wir das Medikament vom Hausarzt. ... Onmeda Brand Names/Synonyms: Reminyl is also known by the following brand names and/or synonymsGalantamin; Galantamine; Galanthamine; Galanthamine Base; Galanthamine Hydrobromide; Jilkon; Lycoremin; Lycoremine; Reminyl Drug Category: Reminyl is categorized under the following by the FDA: Nootropic Agents; Parasympathomimetics; Parasympathomimetics; ATC:N06DA04 Dosage Forms: CAPSULE, EXTENDED RELEASE Absorption: Not Available Interactions: Not Available Chemical IUPAC Name: (4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |